Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20 ... “Zepbound promotes weight loss and has been shown to reduce ...

The Food and Drug Administration on Friday approved ... the FDA's director of the division of pulmonology, allergy and critical care. The FDA said the popular weight-loss drug should be combined ...

The FDA also recommends that ... Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep ...

which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023. Although the new FDA green light doesn’t expand the ...

Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what ... In March, the weight loss drug Wegovy was FDA-approved to prevent strokes and heart ...

The Food and Drug Administration on Friday approved Eli Lilly ... the condition by reducing body weight, according to the FDA. The move comes as weight-loss medications have garnered immense ...

Advertising Even before the FDA approval, some doctors have been prescribing weight-loss drugs to people with sleep apnea. The FDA’s decision may place added pressure on insurance companies to ...